Financials
- Financial year
- 2025
- Total assets
- €144,465
- Profit
- €58,804
- Solvency
- 44.2%
FF Médical
ActiveSummary
FF Médical has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €63,804 and a net result of €58,804. The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Activity
“La consultation,le diagnostic,le traitement et le suivi des patients atteints de pathologies internistiques,gastro-intestinales,hépatiques,biliaires et…” (deed in French)
From the articles, 7 activitiesNo NACE code in the KBO yet1 site
Size
€144,465total assets 2025
- Equity
- €63,804
- Profit
- €58,804
Turnover not published (micro format)
Structure
Accounts 11 days early
Why 83raises riskFounded in 2025lowers riskSize: total assets €144,465Liquidity: current ratio 1.24, cash €32,730No main activity registeredShow the evidence
Checked score
Score 2025
83
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 54% of its sector peers (no NACE code, micro)
Financial strength
Strong
Solvency
69
equity 44.2% of total assets
Liquidity
50
short-term debt 55.8% · cash 22.7%
Profitability
100
return on assets 40.7%
Bankruptcy probability, 12 months
0.5%
Very low
0%0.5%1.5%4%10%≥ 25%
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
05-2026: 2.4%
06-2026: 2.4%● unchanged vs 05-2026
07-2026: 2.9%▲ +0.5 percentage points vs 06-2026highest value
08-2026: 0.5%▼ -2.4 percentage points vs 07-2026
09-2026: 0.5%● unchanged vs 08-2026lowest value
10-2026: 0.5%● unchanged vs 09-2026lowest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.24, below the usual 1.5; short-term debt: 55.8% and cash: 22.7% of total assets), and 55.8% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 41% on solvency, 33% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 14-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
11 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: FORTUNATI Florent Pierre Régis…
Key points
By topic
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 04-04-2025
- Year ends
- 31-12
- Peppol
- Not found in the Peppol directory
Articles of association
- Provisions read
- 33
- Annual meeting
- Last Thursday of May at 18:00
- Purpose
- “La consultation,le diagnostic,le traitement et le suivi des patients atteints de…” (deed in French)
- Statutory auditor
- No statutory auditor
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.